Epilog’s Global Clinical Trial Services
De-risk your CNS trial with objective EEG parameters
EEG in CNS trials
As sensitive parameters to characterize patient population and treatment, and evaluate efficacy.
As objective inclusion criteria and/or endpoints.
As validated biomarkers for further development and market access.
A holistic service and unique hybrid solution
4 steps to successfully apply validated EEG endpoints
- CONSULTING - Expert consulting on EEG protocols, pharmacometrics, and biomarker validation.
- COLLECTING - High quality and standardized EEG data collection, at home or in the hospital.
- PROCESSING - Central data collection and processing on secure cloud platform, combining AI and central reading.
- REPORTING - Statistical analysis of endpoints and data reporting.
“Considering EEG in the early stages of clinical development paves the way to validated EEG biomarkers.
Epilog brings a fresh perspective to the table, built on clinical, technical, and practical experience.”